TREATMENT OUTCOME OF TOFACITINIB DOSE REDUCTION TO 5 MG BID VS REMAINING ON 10 MG BID IN PATIENTS WITH UC WHO WERE IN STABLE REMISSION ON 10 MG BID: 6-MONTH DATA FROM THE DOUBLE-BLIND, RANDOMISED RIVETING STUDY

Severine Vermeire  1     Chinyu Su  2     Nervin Lawendy  2     Taku Kobayashi  3     William Sandborn  4     David T. Rubin  5     Irene Modesto     Sean Gardiner     nicole kulisek     Haiying Zhang     Wenjin Wang     Julian PanĂ©s    
1 University Hospitals Leuven,Leuven,Belgium
2 Pfizer Inc,Collegeville, PA,United States
3 Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital,Tokyo,Japan
4 University of California San Diego,La Jolla,United States
5 University of Chicago Medicine, Inflam

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing